Skip to main content
36°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exact Sciences Corporation - Common Stock
(NQ:
EXAS
)
46.35
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
46
Open
46.35
Bid (Size)
44.81 (2)
Ask (Size)
47.98 (3)
Prev. Close
46.35
Today's Range
46.35 - 46.35
52wk Range
40.62 - 79.62
Shares Outstanding
171,948,769
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner
March 12, 2025
From
Exact Sciences Corp.
Via
Business Wire
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week
March 10, 2025
Speculation over an impending reverse merger, a Phase 2 trial announcement, comments about upcoming cancer screening tests, a Medicare business deal, and an obesity drug partnership sparked buzz among...
Via
Stocktwits
Performance
YTD
-18.58%
-18.58%
1 Month
-11.51%
-11.51%
3 Month
-26.61%
-26.61%
6 Month
-27.71%
-27.71%
1 Year
-23.64%
-23.64%
More News
Read More
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
March 01, 2025
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Natera (NTRA) Q4 Earnings: What To Expect
February 26, 2025
Via
StockStory
2 Stocks Down 59% and 34% to Buy and Hold
February 24, 2025
Via
The Motley Fool
Expert Outlook: Exact Sciences Through The Eyes Of 7 Analysts
February 20, 2025
Via
Benzinga
Earnings Scheduled For February 19, 2025
February 19, 2025
Via
Benzinga
Exact Sciences to Participate in March Investor Conferences
February 24, 2025
From
Exact Sciences Corp.
Via
Business Wire
What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?
February 21, 2025
Via
Benzinga
Why Exact Sciences (EXAS) Shares Are Trading Lower Today
February 20, 2025
Via
StockStory
Palantir Rally Loses Steam, Walmart Outlook Disappoints: What's Driving Markets Thursday?
February 20, 2025
Via
Benzinga
Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript
February 20, 2025
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Exact Sciences Stock Slides On Q4 Earnings: The Details
February 19, 2025
Via
Benzinga
Exact Sciences’s (NASDAQ:EXAS) Q4: Beats On Revenue
February 19, 2025
Via
StockStory
Exact Sciences Announces Fourth Quarter 2024 Results
February 19, 2025
From
Exact Sciences Corp.
Via
Business Wire
Trump Calls For More Tariffs, Federal Reserve Minutes On Deck: What's Driving Markets Wednesday?
February 19, 2025
Via
Benzinga
Topics
Economy
Government
World Trade
Exposures
Interest Rates
Political
Tariff
Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect
February 18, 2025
Via
StockStory
10 Health Care Stocks With Whale Alerts In Today's Session
February 14, 2025
Via
Benzinga
Exact Sciences Schedules Fourth Quarter 2024 Earnings Call
February 03, 2025
From
Exact Sciences Corp.
Via
Business Wire
Forecasting The Future: 19 Analyst Projections For Exact Sciences
January 23, 2025
Via
Benzinga
Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium
January 21, 2025
From
Exact Sciences Corp.
Via
Business Wire
New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients
January 21, 2025
From
Exact Sciences Corp.
Via
Business Wire
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
January 21, 2025
Via
Investor's Business Daily
Exact Sciences Stock Drops 12% Over Four Days. 'What Is Going On?'
January 16, 2025
Via
Investor's Business Daily
2 Healthcare Stocks to Buy Hand Over Fist in January
January 16, 2025
Via
The Motley Fool
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.